Mckesson (MCK) Non Operating Investment Income (2012 - 2013)
Mckesson (MCK) posted quarterly Non Operating Investment Income of $81.0 million for Q2 2013, little changed year-over-year from $81.0 million in Q2 2012, and little changed quarter-over-quarter from $81.0 million in Q2 2012.
Mckesson (MCK) Non Operating Investment Income (2012 - 2013) Analysis & Trends
Mckesson (MCK) has reported Non Operating Investment Income for 2 consecutive years, with $81.0 million the latest figure, recorded in Q2 2013.
- In Q2 2013, Non Operating Investment Income changed 0.0% year-over-year to $81.0 million; the TTM figure through Mar 2014 stood at $81.0 million (changed 0.0% YoY), while the FY2013 annual figure was $81.0 million, changed N/A from the prior year.
- Non Operating Investment Income held at $81.0 million in Q2 2013 per MCK's latest filing, from $81.0 million in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $81.0 million in Q2 2012 and bottomed at $81.0 million in Q2 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | - |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | - |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | - |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | - |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | - |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | - |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | - |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | - |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2013 | 81.00 Mn |
| Jun 30, 2013 | 81.00 Mn |
| Jun 30, 2012 | 81.00 Mn |
| Jun 30, 2012 | 81.00 Mn |